Neogene Therapeutics, Inc. — Form D
Neogene Therapeutics, Inc. of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-09-14. The offering totals $110.0M, of which $110.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-09-14
- Form: D
- Accession: 0001437749-20-019679
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $110.0M
- Amount sold: $110.0M
- Investors: 63
- Date of first sale: 2020-09-02
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-375460
Issuer
- Name: Neogene Therapeutics, Inc.
- CIK: 0001757966
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 689 Fifth Avenue, New York, NY, 10022
- Phone: 212-871-7920
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| Franz NM Humer | Director | New York, NY |
| Rajul Jain | Director | South San Francisco, CA |
| Carsten Linnemann, PhD | Director | New York, NY |
| Rachel NM Mears | Director | New York, NY |
| Elisa NM Petris | Director | New York, NY |
| Antonius NM Schumacher | Director | New York, NY |
| Caroline NM Stout | Director | New York, NY |
| David Tanen | Director | New York, NY |
| Katherine Wood | Director | Fort Worth, TX |
| Carsten Linnemann, PhD | Executive Officer | New York, NY |
| Carsten Linnemann, PhD | Promoter | New York, NY |
| David Tanen | Promoter | New York, NY |
| David M Tanen | Director | New York, NY |
| David M Tanen | Promoter | New York, NY |
| Fei M Chen | Director | New York, NY |
| Helen M Kim | Director | New York, NY |
Other filings by this issuer (1)
More